JP2018516944A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018516944A5 JP2018516944A5 JP2017563314A JP2017563314A JP2018516944A5 JP 2018516944 A5 JP2018516944 A5 JP 2018516944A5 JP 2017563314 A JP2017563314 A JP 2017563314A JP 2017563314 A JP2017563314 A JP 2017563314A JP 2018516944 A5 JP2018516944 A5 JP 2018516944A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- motomeko
- complement
- gvhd
- agent according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1410116.6A GB201410116D0 (en) | 2014-06-06 | 2014-06-06 | Method of treatment |
| EPPCT/EP2015/062742 | 2015-06-08 | ||
| PCT/EP2015/062742 WO2015185760A1 (en) | 2014-06-06 | 2015-06-08 | Ornithodoros moubata complement inhibitor for use in the treatment of complement-mediated diseases in patients with c5 polymorphism |
| PCT/EP2015/079172 WO2016198133A1 (en) | 2015-06-08 | 2015-12-09 | Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host disease |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018516944A JP2018516944A (ja) | 2018-06-28 |
| JP2018516944A5 true JP2018516944A5 (https=) | 2019-01-24 |
| JP6767396B2 JP6767396B2 (ja) | 2020-10-14 |
Family
ID=51266841
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016571246A Active JP7045133B2 (ja) | 2014-06-06 | 2015-06-08 | Ｃ５多型を有する患者における補体媒介性疾患の治療に使用するためのオルニトドロス・モウバタ（Ｏｒｎｉｔｈｏｄｏｒｏｓ ｍｏｕｂａｔａ）補体阻害剤 |
| JP2017563314A Expired - Fee Related JP6767396B2 (ja) | 2014-06-06 | 2015-12-09 | 急性移植片対宿主病の治療に使用するためのオルニトドロス・モウバタ補体阻害剤 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016571246A Active JP7045133B2 (ja) | 2014-06-06 | 2015-06-08 | Ｃ５多型を有する患者における補体媒介性疾患の治療に使用するためのオルニトドロス・モウバタ（Ｏｒｎｉｔｈｏｄｏｒｏｓ ｍｏｕｂａｔａ）補体阻害剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US11052129B2 (https=) |
| EP (1) | EP3151851B1 (https=) |
| JP (2) | JP7045133B2 (https=) |
| KR (1) | KR102439717B1 (https=) |
| CN (1) | CN106659767B (https=) |
| AU (1) | AU2015270396B2 (https=) |
| BR (1) | BR112016028446A2 (https=) |
| CA (1) | CA2951175A1 (https=) |
| DK (2) | DK3151851T3 (https=) |
| ES (2) | ES2906630T3 (https=) |
| GB (1) | GB201410116D0 (https=) |
| IL (1) | IL249237B (https=) |
| MX (1) | MX382757B (https=) |
| PL (2) | PL3151851T3 (https=) |
| RU (1) | RU2700932C2 (https=) |
| WO (1) | WO2015185760A1 (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201410116D0 (en) | 2014-06-06 | 2014-07-23 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| CA2988313A1 (en) * | 2015-06-08 | 2016-12-15 | Volution Immuno Pharmaceuticals Sa | Ornithodoros moubata complement inhibitor for use in the treatment of acute graft versus host disease |
| GB201602802D0 (en) * | 2016-02-17 | 2016-03-30 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| EP3464351A1 (en) * | 2016-06-07 | 2019-04-10 | Novartis AG | Anti-c5 antibody for treating patients with complement c5 polymorphism |
| SE540754C2 (en) * | 2016-11-30 | 2018-10-30 | Ikea Supply Ag | Molding of fiber blanks into three-dimensional fiber block |
| ES2945433T3 (es) | 2017-04-21 | 2023-07-03 | Volution Immuno Pharmaceuticals Sa | Coversina para el tratamiento de enfermedades ampollares autoinmunes |
| CN110831617A (zh) * | 2017-04-21 | 2020-02-21 | 沃卢申伊缪诺制药公司 | 用于治疗瘢痕性眼部发炎性病症的Coversin |
| WO2019186084A1 (en) * | 2018-03-26 | 2019-10-03 | The University Of Liverpool | Anti-complement histones |
| US20220047673A1 (en) * | 2018-09-10 | 2022-02-17 | Volution Immuno Pharmaceuticals Sa | Coversin for Use in the Treatment of Rheumatic Diseases |
| GB201905810D0 (en) * | 2019-04-25 | 2019-06-05 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| GB202218084D0 (en) | 2022-12-01 | 2023-01-18 | Volution Immuno Pharmaceuticals Sa | Fusion proteins |
| GB202408081D0 (en) | 2024-06-06 | 2024-07-24 | Volution Immuno Pharmaceuticals Sa | Methods of removing impurities |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20050054033A9 (en) * | 1995-08-30 | 2005-03-10 | Human Genome Sciences, Inc. | Methods and compositions for treating and preventing infection using human interferon regulatory factor 3 |
| JP4772667B2 (ja) | 2003-06-02 | 2011-09-14 | エヴォルーテック・リミテッド | 補体阻害剤 |
| GB0312619D0 (en) * | 2003-06-02 | 2003-07-09 | Evolutec Ltd | Complement inhibitors |
| GB0518443D0 (en) * | 2005-09-09 | 2005-10-19 | Evolutec Ltd | Method of treating myasthenia gravis |
| PL2061501T3 (pl) | 2006-09-08 | 2016-01-29 | Volution Immuno Pharmaceuticals Sa | Sposób leczenia zaburzeń oddechowych |
| GB0617734D0 (en) * | 2006-09-08 | 2006-10-18 | Evolutec Ltd | Method of treating peripheral nerve disorders |
| GB0802116D0 (en) | 2008-02-05 | 2008-03-12 | Natural Enviromental Res Counc | Treatment |
| GB0906779D0 (en) | 2009-04-20 | 2009-06-03 | Natural Environment Res Council | Composition |
| AU2011204483B2 (en) * | 2010-01-08 | 2016-02-11 | Volution Immuno Pharmaceuticals Sa | EV576 for use in the treatment of viral infections of the respiratory tract |
| TW201418707A (zh) * | 2012-09-21 | 2014-05-16 | Alexion Pharma Inc | 補體組分ｃ５拮抗劑之篩選分析 |
| GB201410116D0 (en) | 2014-06-06 | 2014-07-23 | Volution Immuno Pharmaceuticals Sa | Method of treatment |
| ES2945433T3 (es) | 2017-04-21 | 2023-07-03 | Volution Immuno Pharmaceuticals Sa | Coversina para el tratamiento de enfermedades ampollares autoinmunes |
-
2014
- 2014-06-06 GB GBGB1410116.6A patent/GB201410116D0/en not_active Ceased
-
2015
- 2015-06-08 RU RU2016151179A patent/RU2700932C2/ru active
- 2015-06-08 EP EP15728491.0A patent/EP3151851B1/en active Active
- 2015-06-08 MX MX2016016139A patent/MX382757B/es unknown
- 2015-06-08 KR KR1020167036998A patent/KR102439717B1/ko active Active
- 2015-06-08 AU AU2015270396A patent/AU2015270396B2/en not_active Ceased
- 2015-06-08 ES ES15728491T patent/ES2906630T3/es active Active
- 2015-06-08 US US15/315,136 patent/US11052129B2/en active Active
- 2015-06-08 DK DK15728491.0T patent/DK3151851T3/da active
- 2015-06-08 BR BR112016028446A patent/BR112016028446A2/pt active Search and Examination
- 2015-06-08 PL PL15728491T patent/PL3151851T3/pl unknown
- 2015-06-08 JP JP2016571246A patent/JP7045133B2/ja active Active
- 2015-06-08 WO PCT/EP2015/062742 patent/WO2015185760A1/en not_active Ceased
- 2015-06-08 CN CN201580040646.5A patent/CN106659767B/zh active Active
- 2015-06-08 CA CA2951175A patent/CA2951175A1/en active Pending
- 2015-12-09 DK DK15807907.9T patent/DK3302519T3/da active
- 2015-12-09 PL PL15807907T patent/PL3302519T3/pl unknown
- 2015-12-09 US US15/577,906 patent/US20180193417A1/en not_active Abandoned
- 2015-12-09 ES ES15807907T patent/ES2906632T3/es active Active
- 2015-12-09 JP JP2017563314A patent/JP6767396B2/ja not_active Expired - Fee Related
-
2016
- 2016-11-27 IL IL249237A patent/IL249237B/en active IP Right Grant
-
2021
- 2021-05-28 US US17/333,675 patent/US20210283221A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018516944A5 (https=) | ||
| Speer et al. | Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2 | |
| Chamorro et al. | The immunology of acute stroke | |
| JP5759445B2 (ja) | 病原体に対する哺乳類先天性免疫抵抗性の刺激のための組成物 | |
| US20250221936A1 (en) | Engineered hemichannels, engineered vesicles, and uses thereof | |
| JP6992201B2 (ja) | 合成ペプチド化合物及び使用方法 | |
| JP2017518316A5 (https=) | ||
| JP2021523103A (ja) | Ｉｌ−３３を含有するマトリックス結合型小胞（ｍｂｖｓ）およびそれらの使用 | |
| PE20130314A1 (es) | PORCIONES DE ENLACE A ANTI-C5a CON ALTA ACTIVIDAD DE BLOQUEO | |
| JP2016531910A5 (https=) | ||
| JP2015522264A5 (https=) | ||
| JP2011528332A (ja) | 哺乳動物ベータ・デフェンシンを用いた炎症性疾患の処置 | |
| ES2738287T3 (es) | Inhibidor de la formación de trampas extracelulares en leucocitos | |
| Sacks et al. | Targeting complement at the time of transplantation | |
| WO2011149964A3 (en) | Methods for treating or preventing vascular graft failure | |
| JPWO2019107530A5 (https=) | ||
| JP2019533722A5 (https=) | ||
| JP2015510393A5 (https=) | ||
| US11130783B2 (en) | CD40 targeted peptides and uses thereof | |
| JP2017522288A5 (https=) | ||
| WO2016044493A1 (en) | Compositions and methods for treating acute radiation syndrome | |
| EA202190310A1 (ru) | Белок для лечения воспалительных заболеваний | |
| JP2011528334A5 (https=) | ||
| WO2013130499A1 (en) | Compositions and methods for cxcr4 signaling and umbilical cord blood stem cell engraftment | |
| AU2016317574A1 (en) | Compositions and methods for the treatment of neurodamage |